Document is current
Any future updates will be listed below
-
Authors
Gao, Yuan
Xia, Yangchen
Li, Jiayao
Lai, Yongfeng
Yin, Songlin
Lin, Junhong
Yu, Dongrunhan
Huang, Shanshan
Lu, Fujia
Wang, Weimin
Chu, Qian
-
Funding
Funding for this research was provided by:
Fundamental Research Funds for the Central Universities (202410487233)
National Natural Science Foundation of China (82503740, 82102930, 32370827, 82072597)
Natural Science Foundation of Hubei Province (2022CFA056)
- License Information
-
More Information
Article History
Received: 25 March 2025
Accepted: 24 September 2025
First Online: 5 November 2025
Declaration
:
: The study protocol was approved by the institutional ethics board of Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology (TJ-IRB20200731), and conducted following the Declaration of Helsinki, the International Ethical Guidelines for Health-related Research Involving Humans of Council for International Organizations of Medical Sciences, and the Approach to the Ethical Review of Biomedical Research Involving Humans (2016) of Ministry of Health of the People’s Republic of China. Human plasma was collected from 69 patients with advanced NSCLC at Tongji Hospital, Huazhong University of Science and Technology. All human samples were obtained with the participants’ informed consent.
: All animal experiments were approved by the animal ethics committee of the Huazhong University of Science and Technology (2024 IACUC number 4401).
: The authors declare no competing interests.
